RT Journal Article
SR Electronic
T1 Differential ventilation using flow control valves as a potential bridge to full ventilatory support during the COVID-19 crisis: From bench to bedside
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.14.20053587
DO 10.1101/2020.04.14.20053587
A1 Levin, Matthew A.
A1 Chen, Martin D.
A1 Shah, Anjan
A1 Shah, Ronak
A1 Zhou, George
A1 Kane, Erica
A1 Burnett, Garrett
A1 Ranginwala, Shams
A1 Madek, Jonathan
A1 Gidicsin, Christopher
A1 Park, Chang
A1 Katz, Daniel
A1 Salter, Benjamin
A1 Kohli-Seth, Roopa
A1 Lin, Hung-Mo
A1 Eisenkraft, James B.
A1 Uysal, Suzan
A1 McCarry, Michael
A1 Reich, David L.
A1 Leibowitz, Andrew B.
YR 2020
UL http://medrxiv.org/content/early/2020/04/21/2020.04.14.20053587.abstract
AB Background It has been projected that there will be too few ventilators to meet demand during the COVID-19 (SARS CoV-2) pandemic. Ventilator sharing has been suggested as a crisis standard of care strategy to increase availability of mechanical ventilation. The safety and practicality of shared ventilation in patients is unknown. We designed and evaluated a system whereby one mechanical ventilator can be used to simultaneously ventilate two patients who have different lung compliances using a custom manufactured flow control valve to allow for individual adjustment of tidal volume and airway pressure for each patient.Methods The system was first evaluated in a simulation lab using two human patient simulators under expected clinical conditions. It was then tested in an observational study of four patients with acute respiratory failure due to COVID-19. Two separately ventilated COVID-19 patients were connected to a single ventilator for one hour. This intervention was repeated in a second pair of patients. Ventilatory parameters (tidal volume, peak airway pressures, compliance) were recorded at five minute intervals during both studys. Arterial blood gases were taken at zero, thirty, and sixty minutes. The primary outcome was maintenance of stable acid-base status and oxygenation during shared ventilation.Results Two male and two female patients, age range 32-56 yrs, participated. Ideal body weight and driving pressure were markedly different among patients. All patients demonstrated stable physiology and ventilation for the duration of shared ventilation. In one patient tidal volume was increased after 30 minutes to correct a respiratory acidosis.Conclusions Differential ventilation using a single ventilator and a split breathing circuit with flow control valves is possible. A single ventilator could feasibly be used to safely ventilate two COVID-19 patients simultaneously as a bridge to full ventilatory support.Summary Statement Not applicable.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is an observational study to validate performance of a novel ventilator control valve. It is not a clinical trial.Funding StatementInternal fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to in the manuscript will be made available if asked for.